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1H and 13C NMR spectra of compound 1:  
1.06 (m, 1H, H-1a), 1.68 (m, , 1H, H-1b), 1.50 (m, 1H, H-2a), 1.57 (m, 1H, H-2b), 1.18 (m, 1H, 
H-3a), 1.41 (m, 1H, H-3b), 1.13 (m, 1H, H-5), 1.34 (m, 1H, H-6a), 1.75 (m, 1H, H-6b), 2.02 
(m, 1h, H-7a), 2.42 (m, 1H, H-7b), 1.90 (m, H-9), 2.31 (m, 1H, H-11a), 2.49 (m, 1H, H-11b), 
6.76 (t, J= 6.6 Hz, 1H, H-12), 3.41 (d, J=16.8 Hz, 1H, H-14a),  3.46 (d, J=16.7 Hz, 1H, H-
14b), 9.63 (t, J=14.4 Hz, 1H, H-15), 9.40 (s, 1H, H-16), 4.36 (s, 1H, H-17a), 4.86 (s, 1H, H-
17b), 0.89 (s, 3H, H-18), 0.82 (s, 3H, H-19) and 0.72 (s, 3H, H-20). 
39.4 (C-1), 19.5 (C-2), 42.0 (C-3), 33.6 (C-4), 55.8 (C-5), 24.4 (C-6), 38.1 (C-7), 148.4 (C-8), 
56.6 (C-9), 39.8 (C-10), 24.8 (C-11), 160.4 (C-12), 135.0 (C-13), 39.6 (C-14), 197.5 (C-15), 
193.8 (C-16), 108.1 (C-17), 33.7 (C-18), 22.1 (C-19) and 14.6 (C-20).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound 1 
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1H NMR spectra of compound 1: 
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1H NMR spectra (expanded) of compound 1: 
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1H NMR spectra (expanded) of compound 1: 
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13C NMR spectra of compound 1:  
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HSQC NMR spectra of compound 1:  
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HMBC NMR spectra of compound 1:  
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HRMS (High Resolution Mass Spectroscopy) of compound 1: 
The high resolution of mass spectroscopy showed the [M+H]+ at m/z 303.23122 
(calculated for C20H31O2, at 303.224580) corresponding to the molecular formula of 1 
as C20H30O2. 
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1H and 13C NMR spectra of compound 2: 
4.63 (d, J= 7.5 Hz, 1H, H-1), 5.20 (d, J= 7.5Hz, 1H, H-3), 2.20 (m, 1H, H-4a), 2.24 (m, 1H, H-
4b); 2.35 (m, 2H, H-5), 4.82, dd, J= 10.2, 4.4 Hz, 1H, H-7), 1.87 (m, 1H, H-8a), 2.32 (m, 1H, 
H-8b); 5.23 (d, J= 16.2 Hz, 1H, H-10), 5.56 (dd, J= 16.2, 7.5 Hz, 1H, H-11), 1.65 (s, 3H, H-
12), 1.43 (s, 3H, H-13), 1.04 (s, 3H, H-14) and 1.06 (s, 3H, H-15). 
 78.8 (C-1), 142.2 (C-2), 124.8(C-3), 24.4 (C-4), 39.5 (C-5), 133.2 (C-6), 125.0 (C-7), 42.4 (C-
8), 37.3 (C-9), 139.5 (C-10), 131.2 (C-11), 12.8 (C-12), 15.3 (C-13),  24.9 (C-14) and 29.9 (C-
15). 
 
 
 
 
 
 
 
 
 
 
 
Compound 2 
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1H NMR spectra of compound 2 
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1H NMR spectra (expanded) of compound 2 
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13C NMR spectra of compound 2 
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COSY of compound 2: 
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HSQC of compound 2: 
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HMBC of compound 2: 
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HRMS (High Resolution Mass Spectrometry) of compound 2: 
The high resolution of mass spectroscopy showed the [M+H]+ at m/z 221.18956 
(calculated for C15H25O, at 221.19054) corresponding to the molecular formula of 2 as 
C15H24O. 
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Figure S1: Antibacterial screening of compounds 1-3 and norfloxacin against MRSA 
strains: 
(1= Compound 1; 2= Compound 2; 3=compound 3 and Nor= Norfloxacin) 
 
 
MICs against ATCC 25923 MICs against SA1199B 
MICs against EMRSA 15 
MICs against MRSA 274829 
MICs against MRSA 340702 MICs against XU212 
